Cardiovascular disease risk management in HIV patients, experiences from Greater Manchester

Area of Science:

• Internal Medicine
• Cardiology
• Infectious Diseases

Background:

• Antiretroviral (ARV) therapy for Human Immunodeficiency Virus (HIV) is associated with metabolic complications.
• These complications, including hyperlipidemia, glucose intolerance, and insulin resistance, significantly elevate the risk of cardiovascular disease (CVD).
• Effective management of these risk factors is crucial for improving long-term outcomes in HIV patients.

Purpose of the Study:

• To audit the prevalence of cardiovascular disease (CVD) risk factors in HIV patients undergoing ARV therapy.
• To assess the current management strategies for these risk factors.
• To recommend improvements in patient care for managing ARV-associated CVD risks.

Main Methods:

• An audit was conducted among HIV patients receiving ARV therapy in Manchester.
• Data on CVD risk factors and their management were collected and analyzed.
• Patient records were reviewed to evaluate the adequacy of risk factor management.

Main Results:

• Cardiovascular disease (CVD) risk factors were found to be highly prevalent among HIV patients on ARV therapy.
• The management of identified CVD risk factors was suboptimal.
• There is a clear need for enhanced strategies to address these risks.

Conclusions:

• A systematic approach to identifying and managing CVD risk factors in HIV patients is essential.
• Formalized systems and appropriate specialist referrals are required to manage complications arising from ARV therapy.
• Implementing these changes will improve the cardiovascular health and overall care of HIV patients.